Nexstim Agrees on a
Nexstim Agrees on a Strategic Investment into a Management Services Organization of a New Jersey Based Clinic Providing Treatments for Depression Patients
04 janv. 2024 02h00 HE | Nexstim Oyj
Press release, Helsinki, 4 January 2024 at 9 AM (EET) Nexstim Agrees on a Strategic Investment into a Management Services Organization of a New Jersey Based Clinic Providing Treatments for Depression...
Nexstim receives Nex
Nexstim receives Nexstim NBS System 5 order from Distributor in Europe
29 déc. 2023 03h00 HE | Nexstim Oyj
Press release, Helsinki, 29 December 2023 at 10 AM (EEST) Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS System 5 from a distributor company based in Europe. ...
Nexstim receives Nex
Nexstim receives Nexstim NBS System 5 order from Europe for Neurosurgery and Neuroscience Use
22 déc. 2023 02h00 HE | Nexstim Oyj
Press release, Helsinki, 22 December 2023 at 9 AM (EET) Nexstim receives Nexstim NBS System 5 order from Europe for Neurosurgery and Neuroscience Use Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company")...
Global Neuronavigation Systems Market
Global Neuronavigation System Market Set to Reach $4.58 Billion by 2031, Driven by Rising Prevalence of Neurological Conditions
06 oct. 2023 04h43 HE | Research and Markets
Dublin, Oct. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Neuronavigation Systems Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...
Global Neuroprosthetics Market
In-Depth Market Research Report Highlights Drivers, Challenges, and Key Players in the Growing Neuroprosthetics Industry
27 sept. 2023 08h28 HE | Research and Markets
Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Neuroprosthetics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global Neuroprosthetics Market...
Nexstim Releases NBS
Nexstim Releases NBS 6 in the United States
17 avr. 2023 02h00 HE | Nexstim Oyj
Press release, Helsinki, 17 April 2023 at 9 AM (EEST) Nexstim Releases NBS 6 in the United States Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces the launch of NBS 6, a new navigated...
22157.jpg
Global Neuromodulation Device Market Report 2023: Sector to Reach $8.2 Billion by 2029 at a 7.4% CAGR
04 avr. 2023 10h53 HE | Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Device Market Size, Share & Trends Analysis 2023-2029 MedCore Includes: Spinal Cord Stimulation, Deep Brain Stimulation,...
Nexstim Receives an
Nexstim Receives an NBT® System Order from Alamo Neurosurgical Institute
25 oct. 2022 02h00 HE | Nexstim Oyj
Press release, Helsinki, 25 October 2022 at 9 AM (EEST) Nexstim Receives an NBT® System Order from Alamo Neurosurgical Institute Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces...
Nexstim NBS 5+ Syste
Nexstim NBS 5+ System Continues to Generate Interest in the US
06 oct. 2022 05h00 HE | Nexstim Oyj
Press release, Helsinki, 6 October 2022 at 12 PM (EEST) Nexstim NBS 5+ System Continues to Generate Interest in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Drs....
Nexstim Receives an
Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital
02 juin 2022 03h00 HE | Nexstim Oyj
Press release, Helsinki, 2 June 2022 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") today...